title: Management of neutrophilic dermatoses.
abstract: Neutrophilic dermatoses, including Sweet's syndrome, pyoderma gangrenosum, and rheumatoid neutrophilic dermatitis, are inflammatory conditions of the skin often associated with underlying systemic disease. These are characterized by the accumulation of neutrophils in the skin. The associated conditions, potential for systemic neutrophilic infiltration, and therapeutic management of these disorders can be similar. Sweet's syndrome can often be effectively treated with a brief course of systemic corticosteroids. Pyoderma gangrenosum, however, can be recurrent, and early initiation of a steroid-sparing agent is prudent. Second-line treatment for both of these conditions includes medications affecting neutrophil function, in addition to immunosuppressant medications.
authors: Division of Dermatology, University of Louisville, 310 East Broadway, Louisville, KY 40202, USA. courtney.schadt@louisville.edu
authors: Courtney R
authors: CR
authors: Schadt
authors: Jeffrey P
authors: JP
authors: Callen
mesh_terms: D001172:Arthritis, Rheumatoid / Q000150:complications / Q000473:pathology; D003872:Dermatitis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy* / Q000473:pathology; D020556:Neutrophil Infiltration; D009504:Neutrophils / Q000378:metabolism*; D017511:Pyoderma Gangrenosum / Q000188:drug therapy / Q000473:pathology; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology; D016463:Sweet Syndrome / Q000188:drug therapy / Q000473:pathology
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents